What is Aquestive Therapeutics, Inc.'s net change in cash?

Aquestive Therapeutics, Inc. (AQST) reported net change in cash of -$10.44M in Q1 2026.

How has Aquestive Therapeutics, Inc.'s net change in cash changed year-over-year?

Aquestive Therapeutics, Inc.'s net change in cash decreased by 261.2% year-over-year, from -$2.89M to -$10.44M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Aquestive Therapeutics, Inc. AQST Net Change in Cash

Net Change in Cash at other companies

Indivior Pharmaceuticals, Inc. INDV

-$20M-138%

ARS Pharmaceuticals, Inc.SPRY

-$17M-55.2%

ViatrisVTRS

$457.7M+2,166%

AMP

Amphastar PharmaceuticalsAMPH

$762K-97.6%

AptarGroupATR

-$179.9M-83.6%

AbbVieABBV

$4.16B+1,293%

Other financials

Income statement

See full

Revenue$14.4M+65.7%

Gross profit$11.0M+117%

Operating income-$4.2M+78.3%

Net income-$8.1M+64.9%

EPS (diluted)-$0.07+70.8%

Balance sheet

See full

Cash & equivalents$110.7M+61.3%

Total debt$64.4M+7.4%

Total equity-$34.1M+44.1%

Total assets$141.1M+38.0%

Cash flow

See full

Operating cash flow-$14.8M+36.7%

CapEx$52.0K-61.5%

Free cash flow-$14.9M+36.9%

Valuation

See full

Market cap$560.13M+73.5%

Enterprise value$513.76M+63.6%

P/S11.1×+5.2×

Profitability

See full

Gross margin63.5%-4.9pp

Operating margin-111.2%+96.3pp

Net margin-137.1%+80.7pp

FCF margin-88.2%-2.2pp

Returns & leverage

See full

Return on equity145.1%—

Debt / equity-1.9×—

Current ratio4.1×-0.8×

Where this comes from

Reported directly by Aquestive Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aquestive Therapeutics, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aquestive Therapeutics, Inc.'s net change in cash?: Aquestive Therapeutics, Inc. (AQST) reported net change in cash of -$10.44M in Q1 2026.
How has Aquestive Therapeutics, Inc.'s net change in cash changed year-over-year?: Aquestive Therapeutics, Inc.'s net change in cash decreased by 261.2% year-over-year, from -$2.89M to -$10.44M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.